Metabolic, Intestinal, and Cardiovascular Effects of Sotagliflozin Compared With Empagliflozin in Patients With Type 2 Diabetes: A Randomized, Double-Blind Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.